In Smith v. Van Gorkom, 1 the Delaware Supreme Court held that the directors of Trans Union Corporation breached their fiduciary duty of care by approving a merger without adequate information on the fairness of the offered price of $55 per share.' Trans Union's directors, who relied solely on their chairman for the valuation of the transaction,' did not follow the common practice of asking an investment banker to render a fairness opinion. 4 The court suggested that, although fairness opinions were not required by law, the directors could have exercised an informed business judgment by obtaining such an opinion. 5 As one of the few cases imposing personal liability on the reputable directors of a major corporal. 488 A.2d 858 (Del. 1985). 2. Id. at 874. The existence of a substantial premium over market value, without more information, did not provide an adequate basis for approving the transaction. Id. at 869 n.9 (offered price represented premium of 62% over average of Trans Union's high and low prices during previous nine months, and premium of 48% over last closing price). 3. Id. at 876-77. At the time of the directors' decision, no formal analysis (either in-house or outside) of Trans Union's value in an acquisition had been prepared. The chief financial officer's brief oral statement to the directors regarding the feasibility of a leveraged buyout did not constitute an adequate valuation study or "report" on which the directors could rely as defined by DEL. CODE ANN. tit. 8, § 141(e) (1983). Van Gorkom, 488 A.2d at 875. 4. Directors ask investment bankers to render fairness opinions in a wide variety of corporate control transactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.